View Dividendこのページの翻訳は実験的なもので、現在開発中です。フィードバックをお待ちしております!Femtobiomed マネジメントマネジメント 基準チェック /04現在、CEO に関する十分な情報がありません。主要情報 最高経営責任者n/a報酬総額CEO給与比率n/aCEO在任期間no dataCEOの所有権n/a経営陣の平均在職期間データなし取締役会の平均在任期間データなし経営陣の近況更新なしすべての更新を表示Recent updatesFemtobiomed Inc. announced that it has received KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.Apr 24Femtobiomed Inc. announced that it expects to receive KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.Mar 26New major risk - Share price stability Feb 02New major risk - Share price stability Oct 21Femtobiomed Inc. announced that it has received KRW 5.9999868 billion in fundingFeb 27+ 1 more updateFemtobiomed Inc. announced that it expects to receive KRW 5.9999868 billion in fundingFeb 11New 90-day low: ₩16,450 Oct 16New 90-day high - ₩20,500 Aug 07CEO(最高経営責任者Femtobiomed CEOがいない、あるいは彼らに関するデータがない。View Ownership
Femtobiomed Inc. announced that it has received KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.Apr 24
Femtobiomed Inc. announced that it expects to receive KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.Mar 26
Femtobiomed Inc. announced that it has received KRW 5.9999868 billion in fundingFeb 27+ 1 more update